https://scholars.lib.ntu.edu.tw/handle/123456789/397532| Title: | Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: Pooled analysis of two phase 3 trials | Authors: | JIA-HORNG KAO Jensen, Donald M. Asselah, Tank Dieterich, Douglas Foster, Graham R. Sulkowski, Mark S. Zeuzem, Stefan Manny, Parvez Yoshida, Eric M. Moreno, Christophe Ouzan, Denis Wright, Mark Morano, Luis E. Buynak, Robert Bourliere, Marc Hassanein, Tarek Nishiguchi, Shuhei Kao, Jia-Horng Omata, Masao Paik, Seung W. Wong, David K. Tam, Edward Kaita, Kelly Feinman, S. Victor Stern, Jerry O. Scherer, Joseph Quinson, Anne-Marie Voss, Florian Gallivan, John-Paul Boecher, Wulf O. Ferenci, Peter |
Issue Date: | 2016 | Journal Volume: | 15 | Journal Issue: | 3 | Start page/Pages: | 333-349 | Source: | Annals of Hepatology | URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84963705855&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/397532 |
DOI: | 10.5604/16652681.1198803 |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
